You might notice Lisa Z was not offered any performance shares...

You might notice Lisa Z was not offered any performance shares which tells you something.

As for JS vs our new MD - who would you think is best to lead this company given their backgrounds?

You can bang on about how important JS and Lisa are. But contrary to your little grandstanding you seem to ignore the pedigree we have with Dr Sheng and JS's replacement Ie Martin.

JS was replaced as CEO back in April and how many former CEO's do you see hanging around companies for very long.

I don't need to debate with you on these subjects as i don't find it very relevant to the bigger picture and being back here just presented me with a good buying opportunity. Tell you what you sit on the sidelines and let's compare notes on where the share price is at end of September!